| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/10/2008 | WO2007081779A3 Methods of determining cutoff points |
| 07/10/2008 | WO2007059019A3 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 07/10/2008 | US20080167549 Method for enhancing contrast produced by MRI |
| 07/10/2008 | US20080166301 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne |
| 07/10/2008 | US20080166300 Screening for agents that modulate a cancer associated phosphatase function; combining a candidate biologically active agent with a polypeptide having phosphatase activity; assessing the effectiveness on cancer cells |
| 07/10/2008 | US20080166298 6- (2, 3, 4, 5-Tetrahydro-1H-Benzo [D] Azepin-7-Yloxy) -Nicotamide Derivatives as Radio Labelled Ligands |
| 07/10/2008 | US20080166296 Pharmaceutical Gallium Compositions and Methods |
| 07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 07/10/2008 | DE102007001393A1 Beschichtete Bariumsulfatnanopartikel als Kontrastmittel Coated barium sulphate nanoparticles as contrast agents |
| 07/10/2008 | CA2674226A1 Compositions and methods of their use for improving the condition and appearance of skin |
| 07/09/2008 | EP1941279A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging |
| 07/09/2008 | EP1940841A2 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 07/09/2008 | EP1940475A2 Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging |
| 07/09/2008 | EP1940473A2 Multiphoton in vivo flow cytometry method and device |
| 07/09/2008 | EP1940370A2 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity |
| 07/09/2008 | EP1940295A2 Resonant nanostructures and methods of use |
| 07/09/2008 | EP1539249B1 Procedures of cellular labelling with paramagnetic complexes for mri applications |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | CN101218353A Predicting treatment response in cancer subjects |
| 07/09/2008 | CN101214168A Animal behavior monitoring and analyzing system |
| 07/09/2008 | CN100400105C Aqueous matrix CT negative contrast medium for digestive tract and its preparation method |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396524 Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy |
| 07/08/2008 | CA2458961C Ocular diagnosis of alzheimer's disease |
| 07/08/2008 | CA2427370C Bone cement mixture and x-ray contrast medium as well as method for their preparation |
| 07/08/2008 | CA2253154C Process for the manufacture of amorphous products by means of convection drying |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/08/2008 | CA2162165C Method of evaluating chemotherapeutic agents in vivo |
| 07/03/2008 | WO2008079834A2 Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonists, and their use as mri contrast agents for the detection of infection and inflammation |
| 07/03/2008 | WO2008079408A1 A zebrafish based screen for agents with ability to prevent cell death |
| 07/03/2008 | WO2008078964A1 High screening method for nematicide to b. xylophilus, diplo- scapter and c. elegans |
| 07/03/2008 | WO2008078190A2 Compounds for fluorescence imaging |
| 07/03/2008 | WO2008077993A1 Novel peptides |
| 07/03/2008 | US20080161606 Preparation of iodixanol |
| 07/03/2008 | US20080161423 For suppressing the depression of an organ provided for transplantation; comprising glycyrrhizic acid, glycyrrhetinic acid |
| 07/03/2008 | US20080160098 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160092 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080159997 Transplants for myocardial scars |
| 07/03/2008 | US20080159960 using nuclear magnetic resonance spectroscopy; measured in vivo also on materials that are foreign to the body, e.g. nanoparticles that are heated in the body; consisting of carbon nanotubes shell and a filling of thermosensitive substances; tumor therapy |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | US20080159958 Determination of histamine-3 bioactivity |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/03/2008 | US20080159956 diagnosing and analyzing a mammal who has a risk of developing the disease, using antibody, or fragments thereof, which has a binding site specific for integrin |
| 07/03/2008 | US20080159955 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 07/03/2008 | US20080159954 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 07/03/2008 | DE19983227B4 Überzug zum Sichtbarmachen von medizinischen Einrichtungen bei der magnetischen Resonanz-Abbildung, diesen umfassendes magnetisches Resonanz-Bilderzeugnis-System und Verfahren zum Sichtbarmachen von medizinischen Einrichtungen Coating for visualizing medical devices in magnetic resonance imaging, magnetic resonance images of this comprehensive certificate system and method for visualizing medical devices |
| 07/03/2008 | CA2673560A1 New fusion molecule based on novel taa variant |
| 07/03/2008 | CA2673248A1 Novel peptides |
| 07/02/2008 | EP1937676A1 Biocompatible fluorescent imaging agents |
| 07/02/2008 | EP1937315A2 Imaging agent comprising iron containing colloidal particle conjugated to oligosaccharides |
| 07/02/2008 | EP1937314A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 07/02/2008 | EP1937260A2 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 07/02/2008 | EP1729819B1 X-ray visible drug delivery device |
| 07/02/2008 | EP0969878B1 Method for detecting abnormal epithelial cell shedding |
| 07/02/2008 | CN101209212A Self blood plasma skin experimental approach for detecting chronic urticaria |
| 07/01/2008 | US7393643 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a MDR1-encoding sequence |
| 07/01/2008 | US7393544 Microstructures containing a drug and a suspension medium that permeates into the permeable microstructures; density variations between suspended particles and medium are minimized and attractive forces between microstructures are attenuated, resulting in settling and flocculation resistance |
| 06/26/2008 | WO2008076973A2 Biopsy marker with in situ-generated imaging properties |
| 06/26/2008 | WO2008075968A1 Contrast agents |
| 06/26/2008 | WO2008075522A1 Radioactive diagnostic imaging agent |
| 06/26/2008 | WO2008075192A2 Targeting and therapeutic compounds and gas-filled microvesicles comprising said com ounds |
| 06/26/2008 | WO2008075081A2 Composition and method for detection of demineralisation |
| 06/26/2008 | WO2008074804A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | WO2008074052A1 Tattooing method for radiation therapy |
| 06/26/2008 | WO2008052136A9 Controlled activation ingestible identifier |
| 06/26/2008 | WO2008007290A3 Core-shell nanoparticles for thearapy and imaging purposes |
| 06/26/2008 | WO2007117686A3 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 |
| 06/26/2008 | WO2006127514A3 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080152593 Aggregate of ferromagnetic metal oxides dispersed on each of the carbon nanohorns; low toxicity |
| 06/26/2008 | US20080152592 Creating a diffusion channel in the skin; maintaining the diffusion channel for a duration; continuously monitoring the levels of the therapeutic drug, metabolite or the levels of a substance that is affected by the therapeutiputic drug; analyzing the levels to determine the effectiveness |
| 06/26/2008 | US20080152591 Administering the agent to an externally fertilized teleost;detecting a response of the teleost; and comparing the response of the agent-treated teleost with a response in the brain or CNS of an untreated or control teleost |
| 06/26/2008 | US20080152590 Engraftable Neural Progenitor and Stem Cells for Brain Tumor Therapy |
| 06/26/2008 | US20080152588 Metal Chelators and Methods of Their Use |
| 06/26/2008 | US20080152586 Protein complexes comprising three or more polypeptides, each having multiple immunoglobulin like domains, which associate to form target binding regions, for use as therapeutic, diagnostic or imaging agents |
| 06/26/2008 | CA2682960A1 Composition and methods for the detection of tooth demineralisation |
| 06/26/2008 | CA2672878A1 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies |
| 06/26/2008 | CA2672810A1 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | CA2672262A1 Radioactive diagnostic imaging agent |
| 06/26/2008 | CA2670836A1 Treatment of pigs with pcv2 antigen |
| 06/25/2008 | EP1935978A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 06/25/2008 | EP1935436A1 Nanoparticle clusters and methods for forming same |
| 06/25/2008 | EP1935435A2 Blood pool agents for nuclear magnetic resonance diagnostics |
| 06/25/2008 | EP1934872A2 Development of prodrugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety using in vitro/in silico predictions |
| 06/25/2008 | EP1934583A1 Device and method for luminescence imaging |
| 06/25/2008 | EP1934358A2 Transgenic rosa26-luciferase mice for bioluminescent imaging |
| 06/25/2008 | EP1934211A1 Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels |
| 06/25/2008 | EP1934138A2 Amphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 06/25/2008 | EP1933884A2 Imaging agents and methods of use thereof |
| 06/25/2008 | EP1933883A2 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| 06/25/2008 | EP1933875A2 Conjugates of photosensitisers and antibodies |
| 06/25/2008 | EP1933873A2 Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 06/25/2008 | EP1827507A4 Biological systems analysis |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | CN101204586A Application of Dysbindin and character encoding genes thereof in medicine-preventing and/or schizophrenia-curing |
| 06/25/2008 | CN101204585A Method of building animal model for parkinsonism |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390668 Halogenated xanthan compound |